News | Business | February 25, 2016

GlobalData: Toshiba Medical Attractive Investment in Diagnostic Imaging Market

Canon and Fujifilm among top early bidders looking to expand into CT and MRI markets

Toshiba, investment opportunity, GlobalData analyst, Japan

February 25, 2016 — Investing in Toshiba Medical, which is seeking potential partners, is likely to deliver strong returns for companies looking to expand into the diagnostic imaging space, according to an analyst with research and consulting firm GlobalData. This could be particularly attractive in the Japanese market, according to the analyst.  

Thanks to a growing population with a steady demand for non-invasive diagnostic procedures, imaging devices have remained a lucrative investment, and GlobalData forecasts that the global diagnostic imaging market will be valued at $42.4 billion by 2020.

As Sarah Janer, GlobalData’s analyst covering medical devices, explained: “Toshiba Medical is a steady performer and its sales make up 10 percent of the thriving global market, which is tempting for companies looking to break into diagnostic imaging.

“Japanese firms are especially interested, as Toshiba Medical possesses 19.2 percent of the diagnostic imaging market in Japan. Canon Inc. and Fujifilm are stepping up to bid, and while both offer digital radiography devices, heavy investment in Toshiba Medical could expand their range to computed tomography (CT) and magnetic resonance imaging (MRI) systems.”

GlobalData estimates that the current markets for CT and MRI devices are expanding at compound annual growth rates of 14.3 and 10.4 percent, respectively.

Janer noted: “Investment opportunities are so attractive that Toshiba’s CEO Masashi Muromachi has hinted at already receiving opening bids significantly higher than the reported asking price of $3 billion for an 80 percent share. Canon and Fujifilm have partnered with other firms to improve the strength of their bid, demonstrating a strong eagerness to invest.

“Certainly, as both companies have less than a 3 percent share of the global diagnostic imaging market, a buyout could significantly boost their chances of competing with imaging titans like Siemens or GE Healthcare.”

Although Toshiba ranks fourth for global market share, collaboration could lead to innovation and some fierce competition down the road, depending on what percentage of Toshiba Medical is sold off.

Janer continued: “A 51 percent percent company share could result in some collaboration, but Toshiba’s restructuring plans would need to succeed. Full investment would result in a more stable outlook and a market share increase of up to 20 percent for the successful buyer, according to GlobalData.” 

For more information: www.globaldata.com

Related Content

ECR 2018 Spotlights Artificial Intelligence and Current Radiology Trends
News | Interventional Radiology | February 21, 2018
The European Congress of Radiology (ECR) announced the theme of its 2018 annual meeting, Feb. 28-March 4 in Vienna...
Radiography Education Enrollment Shows Marginal Rise in 2017
News | Business | February 15, 2018
Directors of radiography educational programs report the number of enrolled students increased slightly in 2017, while...
Sponsored Content | Videos | Imaging | February 15, 2018
Kiyotaka Fujii, global healthcare senior executive officer and president of Konica Minolta, discusses the company's...
Sponsored Content | Videos | Imaging | February 15, 2018
David Widmann, president and CEO of Konica Minolta, looks at what the future of healthcare can bring to its customers,...
AHRA and Canon Medical Systems Announce 2017 Putting Patients First Grant Winners
News | Patient Engagement | February 14, 2018
The Association for Medical Imaging Management (AHRA) and Canon Medical Systems recently announced the tenth annual...
Patients Lack Information About Imaging Exams
News | Patient Engagement | February 14, 2018
Patients and their caregivers desire information about upcoming imaging examinations, but many are not getting it,...
Vantage Galan 3T XGO Edition MRI system was cleared by the FDA.
Technology | Magnetic Resonance Imaging (MRI) | February 12, 2018
February 12, 2018 — Physicians now have access to more neuro and cardiac...
A Tc99m SPECT cardiac exam showing myocardial perfusion in the heart.

Technetium-99m is primarily used for the detection of cancer and to assess perfusion defects in the heart caused by heart attacks or other conditions.

Feature | Radiopharmaceuticals and Tracers | February 08, 2018 | Dave Fornell
February 8, 2018 — The U.S.

Mark Anastasio, an internationally recognized expert on tomographic image reconstruction, imaging physics and development of novel computed biomedical imaging systems, is the director of a new medical imaging Ph.D. program at Washington University in St. Louis.

News | Imaging | February 05, 2018
February 5, 2018 — The field of imaging science
New Policy Decisions Give Millions Access to HeartFlow FFRct Analysis
News | Cardiac Imaging | February 01, 2018
February 1, 2018 – HeartFlow announced that seven new commercial payers issued positive medical policies covering the
Overlay Init